1988
DOI: 10.1136/ard.47.4.313
|View full text |Cite
|
Sign up to set email alerts
|

Autoantibodies to type II collagen: occurrence in rheumatoid arthritis, other arthritides, autoimmune connective tissue diseases, and chronic inflammatory syndromes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
37
1

Year Published

1990
1990
2012
2012

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 76 publications
(40 citation statements)
references
References 13 publications
1
37
1
Order By: Relevance
“…Thus, both autoreactive T and B cells specific for CII escape deletion in RA, and these are apparently not properly regulated. It is not clear how immunological tolerance to CII is broken and whether this breakage of self tolerance represents an early disease-driving event or an epiphenomenon of late-stage disease [11,12,13]. In this respect our present data provide first evidence that already at very early stages of RA, CII is targeted by autoantibody responses.…”
Section: Discussionmentioning
confidence: 68%
See 1 more Smart Citation
“…Thus, both autoreactive T and B cells specific for CII escape deletion in RA, and these are apparently not properly regulated. It is not clear how immunological tolerance to CII is broken and whether this breakage of self tolerance represents an early disease-driving event or an epiphenomenon of late-stage disease [11,12,13]. In this respect our present data provide first evidence that already at very early stages of RA, CII is targeted by autoantibody responses.…”
Section: Discussionmentioning
confidence: 68%
“…On the other hand, much more is known about the potential of autoantibodies directed toward collagen type II (CII) epitopes, which are recognized in cartilage-specific autoimmune responses in RA patients, to induce an erosive arthritis in naive mice upon antibody transfer [9,10]. However, anti-CII autoantibodies are detectable in the circulation in only 5-15% of RA patients, and divergent data has been published on the issue of whether CII autoimmunity represents an early or late event in the disease course [11,12]. In the present investigation, we tested the hypothesis of whether CII might be a substrate for structural modification by PAD enzymes, which could result in a breakage of self tolerance to this cartilagespecific autoantigen.…”
Section: Introductionmentioning
confidence: 99%
“…Serum antibodies to cartilage collagen and chondrocyte membrane proteins have been detected in joint disease (Niebauer et al 1987, Mollenhauer et al 1988, Paroczai and Nemeth-Csbka 1988, Choi et al 1988). …”
Section: Markersmentioning
confidence: 99%
“…There is evidence for the presence of autoantibodies against proteoglycans and collagens, especially type I1 collagen (5)(6)(7)(8)(9). Parallel studies investigating cell-mediated immune response have documented a T cell responsiveness to these connective tissue elements; however, this response was usually not very vigorous (10)(11)(12)(13) The results obtained in the present investigation demonstrate that there is a striking reactivity against chondrocyte membranes in patients with RA and an unexpected response to both chondrocyte and fibroblast cell membranes in patients with OA; thereby distinguishing these 2 patient groups.…”
mentioning
confidence: 99%